A Wiz Biotech firmou uma cooperação estratégica com a Farmácia Xiamen Luyan em reagentes de antígeno COVID-19
On December 21, Xiamen Wiz Biotech Co., Ltd and Xiamen Luyan Pharmacy Co., Ltd signed a strategic cooperation on supplying and selling WIZBIOTECH COVID-19 antigen test kit. Su Jinkun (Mr.), General manager of Xiamen Luyan Pharmacy, Lin Lin (Ms.), Deputy general manager of Retail Division of Luyan Group, and Wang Xiaozhen (Ms.), general manager of Wiz Biotech, Sales Director Peng Que'en (Mr.) attended the ceremony. The cooperation aims to meet the urgent needs of Xiamen citizens for epidemic prevention and testing, and to be the first person in charge of their own health.
At the beginning of this year, General Office of the State Council made it clear that in addition to nucleic acid testing, antigen testing could be another choice for COVID 19 management. Community residents can purchase COVID-19 reagents for self-testing through retail pharmacies as well as online sales platforms, more covenient to the citizens in need.
As a POCT enterprise engaged in the research, development, production, and sales of rapid diagnostic reagents and instruments, Wiz Biotech Co., Ltd. has applied POCT technology to more than 120 products such as digestive tract diseases, infectious diseases, tumor markers, inflammatory markers, thyroid function, sex hormones, and drugs after ten years of intensive POCT diagnosis. With the product performance of high sensitivity, high specificity, and high accuracy, WIZ POCT products have been recognized by many countries, assist doctors in accurate diagnosis and help patients to get more personalized detection and treatment programs.
